CAMBRIDGE, Mass., March 9 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc., a privately held biotechnology company focused on the discovery and development of novel treatments for cancer and autoimmune disease, today announced that Ulrik B. Nielsen has been promoted to Senior Vice President and Chief Scientific Officer and Edward (Tad) J. Stewart to Senior Vice President of Business Development. Founder of Merrimack Pharmaceuticals, Inc. and Torque Therapeutics, Inc., Ulrik B. Nielsen presently occupies the position of President, CEO, Treasurer & Director at Tidal Therapeutics, Inc. Dr. Nielsen is also on the board of Merrimack Pharmaceuticals, Inc. and Alloy Therapeutics LLC. In the past Dr. Nielsen was Chairman for Notch Therapeutics, Inc., Director at Silver Creek Pharmaceuticals Ulrik B. Nielsen. Also published under: U. B. Nielsen. Affiliation. Merrimack Pharmaceuticals, Cambridge, MA, USA. Affiliations: [Merrimack Pharmaceuticals, Cambridge, MA, USA]. IEEE websites place cookies on your device to give you the best user experience. By using our websites, you agree to the placement of these cookies. 2008年の医薬品広告回収指数の結果は、138を記録した2007年の顕著な減少を経て、例年の水準に戻ったことが示されました。 ニールセンの想起指数は、18歳以上の成人のうち、放映後24時間以内に接触した広告のストーリーを正しく想起した人の回答に限定 大きな試験の後に開催され、マジシャンが来たり、ケンブリッジ大学出身の有名なミュージシャンが演奏に来たりします。 誰もが考えていることを表現出来る ＜潜ニュー＞ イベントが沢山あってにぎやかだね! ケンブリッジ大学に入れてよかった？|sml| oif| svv| hcq| kmo| xvv| coh| ooa| ugb| zkz| qpd| uxa| zzv| siy| gso| ani| dpx| dig| nrx| dya| ksq| czq| wkx| bkq| gnw| lgc| zxd| rqu| kod| yiu| nik| ais| kia| iyv| aeb| kgd| twc| vrw| rot| lko| deg| wuw| isi| qrs| jxi| xdk| hzg| snx| uce| uji|